RASGRF2 and breast carcinoma: The observation that GRF2 is highly expressed in malignant and inflamed breast tissues while SOS1 is highly expressed in malignant as well as non-malignant breast tissues also suggest subtle differences in the involvement of these RasGEFs in breast diseases including breast cancer.